30 Dec, EOD - Indian

SENSEX 78248.13 (-0.57)

Nifty 50 23644.9 (-0.71)

Nifty Bank 50952.75 (-0.70)

Nifty IT 43971.4 (0.57)

Nifty Midcap 100 57189.75 (0.37)

Nifty Next 50 68063.8 (-0.72)

Nifty Pharma 23241.15 (1.01)

Nifty Smallcap 100 18639.95 (-0.62)

30 Dec, EOD - Global

NIKKEI 225 39894.54 (-0.96)

HANG SENG 20041.42 (-0.24)

S&P 5901.37 (-1.25)

Login/Signup

Corporate News

You are Here : Home > News > Corporate News >

(01 Oct 2024, 12:26)

Zydus' transdermal patch manufacturing facility completes USFDA inspection

Zydus Lifesciences has received the EIR report from the USFDA for the inspection conducted at its transdermal patch manufacturing facility located at Pharmez, Ahmedabad. This facility underwent an inspection from 15 to 19 July 2024 and has been classified as Voluntary Action Indicated (VAI).
More News